Invited Speakers:
|
|
P. Jeffrey Conn, Ph.D., Director, Vanderbilt Program in Drug Discovery, Lee E. Limbird Professor of Pharmacology, Vanderbilt University Medical Center Jean-Pierre Changeux, Ph.D., Professor, Institut Pasteur Connie Sanchez, Ph.D., Vice President Neuroscience, Lundbeck Research USA Prof. Dr. Klaus Mohr, Chairman, Pharmacology and Toxicology Section, Institute of Pharmacy, University of Bonn Kenneth A. Jacobson, Ph.D., Acting Chief, Laboratory of Bioorganic Chemistry, National Institutes of Health Kenneth Carlson, Ph.D., Senior Director, Biology, Ascent Therapeutics Marlene A. Jacobson, Ph.D., Senior Investigator, Merck Research Labs Eileen K. Jaffe, Ph.D., Senior Member, Professor, Fox Chase Cancer Center Gilles Tamagnan, Ph.D., Head of Chemistry and Preclinical Research, Institute for Neurodegenerative Disorders & Molecular NeuroImaging, Yale University Y. Gopi Shanker, Ph.D., Sr. Scientist, Neuroscience, Amgen Jurgen Wess, Ph.D., Chief, Molecular Signaling Section, National Institutes of Health, NIDDK Stefano Costanzi, Ph.D., Staff Scientist, Laboratory of Biological Modeling, National Institutes of Health, NIDDK
|
|